Barditch-Crovo, P <br/><br/>
The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  Apr 1999 
 - 428-38 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0009-9236 
<br/><br/><label>Standard No.: </label>10.1016/S0009-9236(99)70138-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibiotics, Antitubercular--pharmacology<br/>Contraceptives, Oral, Hormonal--pharmacokinetics<br/>Cross-Over Studies<br/>Cytochrome P-450 CYP3A<br/>Cytochrome P-450 Enzyme System--metabolism<br/>Double-Blind Method<br/>Enzyme Inhibitors--pharmacology<br/>Ethinyl Estradiol--pharmacokinetics<br/>Female<br/>Follicle Stimulating Hormone--blood<br/>Humans<br/>Luteinizing Hormone--blood<br/>Mixed Function Oxygenases--metabolism<br/>Norethindrone--pharmacokinetics<br/>Prospective Studies<br/>Rifabutin--pharmacology<br/>Rifampin--pharmacology<br/>gamma-Glutamyltransferase--blood